# Bioequivalence Study of Nabumetone 750 mg Tablets of Dr. Reddy's Under Fasting Conditions

> **NCT01164813** · PHASE1 · COMPLETED · sponsor: **Dr. Reddy's Laboratories Limited** · enrollment: 44 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Nabumetone
- **DRUG:** Relafen

## Key facts

- **NCT ID:** NCT01164813
- **Lead sponsor:** Dr. Reddy's Laboratories Limited
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-03
- **Primary completion:** 2006-03
- **Final completion:** 2006-03
- **Target enrollment:** 44 (ACTUAL)
- **Last updated:** 2010-07-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01164813

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01164813, "Bioequivalence Study of Nabumetone 750 mg Tablets of Dr. Reddy's Under Fasting Conditions". Retrieved via AI Analytics 2026-07-04 from https://api.ai-analytics.org/clinical/NCT01164813. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*